Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Oct 28:12:789901.
doi: 10.3389/fimmu.2021.789901. eCollection 2021.

Editorial: Mouse Models of B Cell Malignancies

Affiliations
Editorial

Editorial: Mouse Models of B Cell Malignancies

Gema Perez-Chacon et al. Front Immunol. .
No abstract available

Keywords: B cell neoplasms; GEMM; genetically engineered mouse models; immunosurveillance; mouse leukemia; mouse lymphoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Mouse Models of B Cell Malignancies

References

    1. van de Donk N, Pawlyn C, Yong KL. Multiple Myeloma. Lancet (2021) 397(10272):410–27. doi: 10.1016/S0140-6736(21)00135-5 - DOI - PubMed
    1. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, et al. . Oncogenically Active MYD88 Mutations in Human Lymphoma. Nature (2011) 470(7332):115–9. doi: 10.1038/nature09671 - DOI - PMC - PubMed
    1. Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X, et al. . MYD88 L265P in Waldenstrom Macroglobulinemia, Immunoglobulin M Monoclonal Gammopathy, and Other B-Cell Lymphoproliferative Disorders Using Conventional and Quantitative Allele-Specific Polymerase Chain Reaction. Blood (2013) 121(11):2051–8. doi: 10.1182/blood-2012-09-454355 - DOI - PMC - PubMed
    1. Yu X, Du Y, Cai C, Cai B, Zhu M, Xing C, et al. . Inflammasome Activation Negatively Regulates MyD88-IRF7 Type I IFN Signaling and Anti-Malaria Immunity. Nat Commun (2018) 9(1):4964. doi: 10.1038/s41467-018-07384-7 - DOI - PMC - PubMed
    1. Zapata JM, Llobet D, Krajewska M, Lefebvre S, Kress CL, Reed JC. Lymphocyte-Specific TRAF3 Transgenic Mice Have Enhanced Humoral Responses and Develop Plasmacytosis, Autoimmunity, Inflammation, and Cancer. Blood (2009) 113(19):4595–603. doi: 10.1182/blood-2008-07-165456 - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources